FR11C0028I1 - - Google Patents

Info

Publication number: FR11C0028I1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-16

Filing date

2011-07-28

Publication date

2011-09-23

2011-07-28 Application filed filed Critical

2011-09-23 Publication of FR11C0028I1 publication Critical patent/FR11C0028I1/fr

2012-06-22 Application granted granted Critical

2012-06-22 Publication of FR11C0028I2 publication Critical patent/FR11C0028I2/en

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FR11C0028C 1998-10-16 2011-07-28 NEW IMIDAZOLES WITH ANTI-INFLAMMATORY ACTIVITY Active FR11C0028I2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES9802222		1998-10-16
PCT/ES1999/000327 WO2000023426A1 (en)	1998-10-16	1999-10-15	Novel imidazoles with anti-inflammatory activity

Publications (2)

Publication Number	Publication Date
FR11C0028I1 true FR11C0028I1 (en)	2011-09-23
FR11C0028I2 FR11C0028I2 (en)	2012-06-22

Family

ID=8305557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR11C0028C Active FR11C0028I2 (en)	1998-10-16	2011-07-28	NEW IMIDAZOLES WITH ANTI-INFLAMMATORY ACTIVITY

Country Status (20)

Country	Link
US (1)	US6838476B1 (en)
EP (1)	EP1122243B1 (en)
JP (1)	JP4480894B2 (en)
KR (2)	KR100808433B1 (en)
AR (1)	AR024222A1 (en)
AT (1)	ATE275549T1 (en)
AU (1)	AU6204899A (en)
BE (1)	BE2011C024I2 (en)
BR (2)	BR9914571A (en)
CA (1)	CA2346847C (en)
CY (1)	CY2011009I2 (en)
DE (2)	DE69920028T2 (en)
DK (1)	DK1122243T3 (en)
ES (1)	ES2228109T3 (en)
FR (1)	FR11C0028I2 (en)
HK (1)	HK1039331B (en)
LU (1)	LU91849I2 (en)
NO (2)	NO319074B1 (en)
PT (1)	PT1122243E (en)
WO (1)	WO2000023426A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK12672001A3 (en)	1999-12-08	2002-04-04	Pharmacia Corporation	Compositions of cyclooxygenase-2 inhibitor having rapid onset of therapeutic effect
ES2159489B1 (en)	2000-03-23	2002-04-16	Uriach & Cia Sa J	NEW IMIDAZOL DERIVATIVES WITH ANTI-INFLAMMATORY ACTIVITY.
ES2166710B1 (en) *	2000-04-25	2004-10-16	J. URIACH & CIA, S.A.	NEW HETEROCICLIC COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY.
ES2184633B1 (en)	2001-08-07	2004-08-01	J. URIACH & CIA, S.A.	PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 4- (IMIDAZOL-1-IL) BENCENOSULFONAMIDE.
MXPA04009961A (en)	2002-04-12	2004-12-13	Pfizer	Imidazole compounds as anti-inflammatory and analgesic agents.
KR100804827B1 (en) *	2002-05-17	2008-02-20	씨제이제일제당 (주)	Thiazolidin-4-one derivative, preparation method thereof, and pharmaceutical composition
ATE548354T1 (en) *	2002-07-24	2012-03-15	Ptc Therapeutics Inc	UREIDO-SUBSTITUTED BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND TREATMENT OF DISEASES
ES2215474B1 (en) *	2002-12-24	2005-12-16	J. URIACH & CIA S.A.	NEW DERIVATIVES OF PHOSPHORAMIDE.
FR2881049B1 (en) *	2005-01-24	2008-12-26	Vetoquinol Sa Sa	MEDICAMENT FOR ORAL ADMINISTRATION COMPRISING A CYCLO-OXYGENASE-2 INHIBITOR, AND PROCESS FOR PREPARING THE SAME
EP2170337A4 (en)	2007-06-28	2013-12-18	Abbvie Inc	Novel triazolopyridazines
GB0806745D0 (en) *	2008-04-14	2008-05-14	Syngenta Participations Ag	Novel imidazole derivatives
WO2010068794A2 (en)	2008-12-10	2010-06-17	The General Hospital Corporation	Hif inhibitors and use thereof
US20110045101A1 (en) *	2009-05-06	2011-02-24	E.I. Du Pont De Nemours And Company	Fungicidal substituted azoles
CN102464652B (en) *	2010-11-02	2013-08-28	北京欧博方医药科技有限公司	Imidazole derivative and preparation method as well application
IL305573A (en)	2021-03-15	2023-10-01	Saul Yedgar	Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3901908A (en) *	1970-12-28	1975-08-26	Ciba Geigy Corp	2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
IT1168008B (en) *	1981-07-31	1987-05-20	Zambon Spa	IMIDAZOL-ETERI AND ESTER, PROCEDURES TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US4576958A (en) *	1984-01-23	1986-03-18	E. I. Du Pont De Nemours And Company	Antihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivatives
US5620999A (en) *	1994-07-28	1997-04-15	Weier; Richard M.	Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5616601A (en) *	1994-07-28	1997-04-01	Gd Searle & Co	1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
EP1288206B1 (en) *	1996-04-12	2008-09-17	G.D. Searle LLC	Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors

1999
- 1999-10-13 AR ARP990105192A patent/AR024222A1/en active IP Right Grant
- 1999-10-15 AU AU62048/99A patent/AU6204899A/en not_active Abandoned
- 1999-10-15 US US09/807,458 patent/US6838476B1/en not_active Expired - Lifetime
- 1999-10-15 DK DK99949025T patent/DK1122243T3/en active
- 1999-10-15 KR KR1020067024215A patent/KR100808433B1/en active IP Right Grant
- 1999-10-15 CA CA002346847A patent/CA2346847C/en not_active Expired - Lifetime
- 1999-10-15 AT AT99949025T patent/ATE275549T1/en active
- 1999-10-15 KR KR1020017004779A patent/KR100715918B1/en active IP Right Grant
- 1999-10-15 DE DE69920028T patent/DE69920028T2/en not_active Expired - Lifetime
- 1999-10-15 DE DE201112100028 patent/DE122011100028I1/en active Pending
- 1999-10-15 JP JP2000577154A patent/JP4480894B2/en not_active Expired - Fee Related
- 1999-10-15 WO PCT/ES1999/000327 patent/WO2000023426A1/en not_active Application Discontinuation
- 1999-10-15 EP EP99949025A patent/EP1122243B1/en not_active Expired - Lifetime
- 1999-10-15 BR BR9914571-5A patent/BR9914571A/en not_active IP Right Cessation
- 1999-10-15 BR BRPI9914571 patent/BRPI9914571B8/en unknown
- 1999-10-15 PT PT99949025T patent/PT1122243E/en unknown
- 1999-10-15 ES ES99949025T patent/ES2228109T3/en not_active Expired - Lifetime
2001
- 2001-04-09 NO NO20011790A patent/NO319074B1/en not_active IP Right Cessation
2002
- 2002-02-04 HK HK02100832.0A patent/HK1039331B/en not_active IP Right Cessation
2011
- 2011-07-27 NO NO2011012C patent/NO2011012I2/en unknown
- 2011-07-27 LU LU91849C patent/LU91849I2/en unknown
- 2011-07-27 BE BE2011C024C patent/BE2011C024I2/fr unknown
- 2011-07-28 FR FR11C0028C patent/FR11C0028I2/en active Active
- 2011-08-10 CY CY2011009C patent/CY2011009I2/en unknown

Also Published As

Publication number	Publication date
HK1039331A1 (en)	2002-04-19
JP4480894B2 (en)	2010-06-16
PT1122243E (en)	2004-12-31
BRPI9914571B8 (en)	2021-07-06
BE2011C024I2 (en)	2019-03-05
BRPI9914571B1 (en)	2011-10-18
NO2011012I2 (en)	2013-05-06
JP2002527508A (en)	2002-08-27
KR20060129102A (en)	2006-12-14
NO319074B1 (en)	2005-06-13
EP1122243B1 (en)	2004-09-08
KR20010080186A (en)	2001-08-22
AU6204899A (en)	2000-05-08
NO20011790L (en)	2001-06-14
ATE275549T1 (en)	2004-09-15
BRPI9914571A (en)	2001-11-06
CA2346847C (en)	2009-12-22
EP1122243A1 (en)	2001-08-08
CA2346847A1 (en)	2000-04-27
LU91849I2 (en)	2011-09-27
NO20011790D0 (en)	2001-04-09
WO2000023426A1 (en)	2000-04-27
HK1039331B (en)	2005-01-07
KR100715918B1 (en)	2007-05-08
DK1122243T3 (en)	2005-01-10
KR100808433B1 (en)	2008-03-03
DE122011100028I1 (en)	2011-12-08
DE69920028T2 (en)	2005-09-22
BR9914571A (en)	2001-11-06
DE69920028D1 (en)	2004-10-14
FR11C0028I2 (en)	2012-06-22
NO2011012I1 (en)	2011-08-08
US6838476B1 (en)	2005-01-04
AR024222A1 (en)	2002-09-25
ES2228109T3 (en)	2005-04-01
CY2011009I1 (en)	2014-04-09
CY2011009I2 (en)	2014-04-09

Publication	Publication Date	Title
BE2014C048I2 (en)	2019-03-05
BE2012C041I2 (en)	2019-03-05
JP2002508533A5 (en)	2006-01-05
FR11C0028I1 (en)	2011-09-23
BRPI9816295A2 (en)	2011-11-22
IN190652B (en)	2003-08-16
JP2618361C (en)	1998-11-25
JP2508334C (en)	1998-03-04
JP2501875C (en)	1998-10-22
JP2607435C (en)	1998-09-03
JP2615696C (en)	1998-10-08
JP2523369Z (en)	1998-07-09
IN189748B (en)	2003-04-19
IN184150B (en)	2000-06-17
JP2622185C (en)	1998-09-24
CN3080939S (en)	1998-07-08
CN3079173S (en)	1998-06-10
CN3083527S (en)	1998-08-26
CN3082758S (en)	1998-08-19
CN3082014S (en)	1998-08-05
CN3081719S (en)	1998-07-29
CN3081498S (en)	1998-07-15
CN3081497S (en)	1998-07-15
CN3083688S (en)	1998-09-02
CN3084033S (en)	1998-09-02